UNAIDS estimated that in 2023, 84% of pregnant women living with HIV were receiving antiretroviral therapy (ART) for the Prevention of Perinatal Transmission of HIV (PPT‐HIV), potentially averting up to 220,000 new HIV infections in newborns. However, despite the scale‐up of PPT‐HIV services, approximately 160,000 children became infected with HIV in 2022 alone. This underscores the urgent need to refocus efforts on addressing the challenges of PPT‐HIV to ensure that sub‐Saharan Africa meets global targets for eliminating new perinatal transmission. This article examines interventions that have demonstrated positive impacts on PPT‐HIV services and recommends their implementation in areas where they are needed. Among these interventions is the critical importance of enhancing community‐based test‐and‐treat initiatives for people of childbearing age and improving access to prenatal care, HIV testing and ART for expectant mothers. Additionally, there is a need to emphasise the role of technology and involve male partners in PPT‐HIV programmes to enhance effectiveness and achieve the desired outcomes.
George Baah (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: